The prognostic value of weight and body composition changes in patients with non‐small‐cell lung cancer treated with nivolumab

BACKGROUND: It is not well known to what extent effectiveness of treatment with immune checkpoint inhibitors in stage IV non‐small‐cell lung cancer (NSCLC) is influenced by weight loss and changes in body composition. Therefore, the goal of this study was to evaluate body composition changes in rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Degens, Juliette H.R.J., Dingemans, Anne‐Marie C., Willemsen, Anna C.H., Gietema, Hester A., Hurkmans, Daan P., Aerts, Joachim G., Hendriks, Lizza E.L., Schols, Annemie M.W.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200425/
https://www.ncbi.nlm.nih.gov/pubmed/33951326
http://dx.doi.org/10.1002/jcsm.12698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200425/
https://www.ncbi.nlm.nih.gov/pubmed/33951326
http://dx.doi.org/10.1002/jcsm.12698

Ejemplares similares